Vaccines
New Vaccine Developed to Combat Current and Future
New Vaccine Developed to Combat Current and Future COVID Viruses

It could combat strains of the COVID virus SARS-CoV-2 that haven`t even emerged yet.

June 2024

Assessing Dengue Vaccine Efficacy and Safety in Pe
Assessing Dengue Vaccine Efficacy and Safety in Pediatric and Adult Populations

Favorable outcomes observed during a two-year follow-up study affirm the efficacy and safety of the dengue vaccine.

March 2024

Efficacy of Bivalent HPV Vaccine in Disadvantaged
Efficacy of Bivalent HPV Vaccine in Disadvantaged Populations

Women residing in more disadvantaged areas demonstrate greater benefits from bivalent HPV vaccination.

March 2024

Heightened Concerns Surrounding Measles Outbreaks
Heightened Concerns Surrounding Measles Outbreaks

The UK and Europe witness a significant surge in measles infections following a decline in vaccine uptake rates.

March 2024

COVID-19 Vaccination: Saving Lives in Europe
COVID-19 Vaccination: Saving Lives in Europe

Noteworthy findings underscore the critical role of COVID-19 vaccination in preserving lives across Europe.

Februery 2024

Effectiveness of Pfizer-BioNTech Vaccine for COVID
Effectiveness of Pfizer-BioNTech Vaccine for COVID-19

Pfizer-BioNTech’s BNT162b2 vaccine demonstrates efficacy across various clinical outcomes in the fight against COVID-19.

Februery 2024

Brazil Introduces National Dengue Vaccine
Brazil Introduces National Dengue Vaccine

A vaccine, boasting an efficacy rate of approximately 79.8%, developed by the Butantan Institute of São Paulo, will undergo regulatory review for approval.

Februery 2024

Brazil Initiates Free Dengue Vaccination Campaign
Brazil Initiates Free Dengue Vaccination Campaign

Prioritization of vaccination for children aged 10 and 11, with continued efforts targeting those aged 14, citing this age group’s elevated hospitalization rates.

Februery 2024

BA.286 Variant and Bivalent Vaccines for COVID-19
BA.286 Variant and Bivalent Vaccines for COVID-19

Bivalent vaccines offer protection against the BA.286 variant of COVID-19, although they may pose a risk of exacerbating illness, according to a study published in Cell.

Februery 2024

Evaluating Interventions to Enhance Childhood Vacc
Evaluating Interventions to Enhance Childhood Vaccination Coverage

A systematic review conducted by Cochrane assesses various strategies aimed at improving childhood vaccination coverage, offering insights into effective intervention approaches.

Februery 2024